Sodium Hydroxide → 4-({1-[(Tert-butoxy)carbonyl]piperidin-4-yl}(methyl)amino)-3,6-dichloropyridine-2-carboxylic acid
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([N:14]([CH3:27])[C:15]2[CH:20]=[C:19]([Cl:21])[N:18]=[C:17]([C:22]([O:24]C)=[O:23])[C:16]=2[Cl:26])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[OH-].[Na+]>C1COCC1>[C:1]([O:5][C:6]([N:8]1[CH2:9][CH2:10][CH:11]([N:14]([CH3:27])[C:15]2[CH:20]=[C:19]([Cl:21])[N:18]=[C:17]([C:22]([OH:24])=[O:23])[C:16]=2[Cl:26])[CH2:12][CH2:13]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of methyl 4-({1-[(tert-butoxy)carbonyl]piperidin-4-yl}(methyl)amino)-3,6-dichloropyridine-2-carboxylate (95 mg, 0.23 mmol) in THF (5 ml) was added 2M aqueous NaOH (2.3 ml, 4.54 mmol) and the reaction mixture was left to stir at room temperature for 16 h after which time the THF was evaporated in vacuo. The aqueous phase was then treated with an aqueous 10% citric acid solution to pH 5-6 and then extracted with EtOAc (3×50 ml), the combined organic phases were then dried with Na2SO4 and evaporated to give the title compound as a white powder (77 mg, 84%). LC-MS 100%, 2.02 min (3.5 minute LC-MS method), m/z=403.9/405.6, 1H NMR (500 MHz, Methanol-d4) δ 7.09 (s, 1H) 4.14-4.22 (m, 2H) 3.80-3.89 (m, 1H) 2.84 (s, 5H) 1.74-1.81 (m, 4H) 1.46 (s, 9H).
Workup
- waitthe reaction mixture was left
- customwas evaporated in vacuo
- additionThe aqueous phase was then treated with an aqueous 10% citric acid solution to pH 5-6
- extractionextracted with EtOAc (3×50 ml)
- dry with materialthe combined organic phases were then dried with Na2SO4
- customevaporated
Sources & evidence
- ORD record
- ord-383b711c77de4a34a4ec9009645ca32d
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09376422B2
Reaction notes
Loading…